Stories on Pharma


September 25th, 2020|

The Curosurf story is a tale of success. To date, the drug has saved the lives of around one million premature babies worldwide. And the story is far from over. Despite being 73, Tore Curstedt returns to the lab every day - the lab where he has developed a new variant of a drug that is set to help many more babies in the future.


September 28th, 2020|

BioArctic is getting closer to producing a drug that substantially limits the development of Alzheimer’s.

Sprint Bioscience/Pelago

November 18th, 2020|

Top research is based on teamwork, with success derived from continually querying results. Pär Nordlund likens the work of a research director to the job of forming a talented corporate team.

Gesynta Pharma

January 22nd, 2021|

In 2020, Gesynta raised SEK 190 million in one of the year’s largest private biotech investments in the Nordic region. Now the company is one step closer to a new drug for systemic sclerosis. The future promises several innovative treatments for a number of inflammatory diseases, including cardiovascular disease and cancer.

Modus Therapeutics

October 1st, 2020|

Many years’ research has led Mats Wahlgren to a possible first drug treatment for acute manifestations of sickle cell anemia - a genetic condition that affects millions of people.


October 1st, 2020|

Oncopeptides has a new drug candidate for the treatment of a form of cancer of the blood, multiple myeloma, under development. KI Innovations played a key role in getting the project underway.